| Imran Aslam, MD | |
|
2830 N Washington St, Bismarck, ND 58503-1482 | |
| (701) 323-6400 | |
| (701) 323-5677 |
| Full Name | Imran Aslam |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 9 Years |
| Location | 2830 N Washington St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992199244 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 0101269771 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Derm Associates Llc | 4688653306 | 36 |
News Archive
The Zika epidemic has long assumed global proportions, experts told the Congress of the European Academy of Neurology in Copenhagen. Europe needs to get prepared to deal with the relentless spread of the health threat, in particular with a view to "imported" infection.
Isis Pharmaceuticals, Inc. announced today that it will receive a $1.25 million contingent payment from Pfizer Inc. triggered by Pfizer's decision to advance EXC 001 into a Phase 2 study.
With a shortage of donor organs, Mayo Clinic is exploring therapeutic strategies for patients with debilitating liver diseases. Researchers are testing a new approach to correct metabolic disorders without a whole organ transplant. Their findings appear in Science Translational Medicine.
DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today it has completed enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of topical agents T4 endonuclease and photolyase to reduce DNA damage induced as measured through gene expression analysis.
› Verified 5 days ago
| Entity Name | Derm Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649271354 PECOS PAC ID: 4688653306 Enrollment ID: O20040716000237 |
News Archive
The Zika epidemic has long assumed global proportions, experts told the Congress of the European Academy of Neurology in Copenhagen. Europe needs to get prepared to deal with the relentless spread of the health threat, in particular with a view to "imported" infection.
Isis Pharmaceuticals, Inc. announced today that it will receive a $1.25 million contingent payment from Pfizer Inc. triggered by Pfizer's decision to advance EXC 001 into a Phase 2 study.
With a shortage of donor organs, Mayo Clinic is exploring therapeutic strategies for patients with debilitating liver diseases. Researchers are testing a new approach to correct metabolic disorders without a whole organ transplant. Their findings appear in Science Translational Medicine.
DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today it has completed enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of topical agents T4 endonuclease and photolyase to reduce DNA damage induced as measured through gene expression analysis.
› Verified 5 days ago
| Entity Name | Virginia Dermatology And Skin Surgery Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598056582 PECOS PAC ID: 0547439200 Enrollment ID: O20200608002431 |
News Archive
The Zika epidemic has long assumed global proportions, experts told the Congress of the European Academy of Neurology in Copenhagen. Europe needs to get prepared to deal with the relentless spread of the health threat, in particular with a view to "imported" infection.
Isis Pharmaceuticals, Inc. announced today that it will receive a $1.25 million contingent payment from Pfizer Inc. triggered by Pfizer's decision to advance EXC 001 into a Phase 2 study.
With a shortage of donor organs, Mayo Clinic is exploring therapeutic strategies for patients with debilitating liver diseases. Researchers are testing a new approach to correct metabolic disorders without a whole organ transplant. Their findings appear in Science Translational Medicine.
DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today it has completed enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of topical agents T4 endonuclease and photolyase to reduce DNA damage induced as measured through gene expression analysis.
› Verified 5 days ago
| Entity Name | Pinnacle Dermatology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861930984 PECOS PAC ID: 8628353380 Enrollment ID: O20210818001337 |
News Archive
The Zika epidemic has long assumed global proportions, experts told the Congress of the European Academy of Neurology in Copenhagen. Europe needs to get prepared to deal with the relentless spread of the health threat, in particular with a view to "imported" infection.
Isis Pharmaceuticals, Inc. announced today that it will receive a $1.25 million contingent payment from Pfizer Inc. triggered by Pfizer's decision to advance EXC 001 into a Phase 2 study.
With a shortage of donor organs, Mayo Clinic is exploring therapeutic strategies for patients with debilitating liver diseases. Researchers are testing a new approach to correct metabolic disorders without a whole organ transplant. Their findings appear in Science Translational Medicine.
DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today it has completed enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of topical agents T4 endonuclease and photolyase to reduce DNA damage induced as measured through gene expression analysis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Imran Aslam, MD Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Imran Aslam, MD 2830 N Washington St, Bismarck, ND 58503-1482 Ph: (701) 323-6400 |
News Archive
The Zika epidemic has long assumed global proportions, experts told the Congress of the European Academy of Neurology in Copenhagen. Europe needs to get prepared to deal with the relentless spread of the health threat, in particular with a view to "imported" infection.
Isis Pharmaceuticals, Inc. announced today that it will receive a $1.25 million contingent payment from Pfizer Inc. triggered by Pfizer's decision to advance EXC 001 into a Phase 2 study.
With a shortage of donor organs, Mayo Clinic is exploring therapeutic strategies for patients with debilitating liver diseases. Researchers are testing a new approach to correct metabolic disorders without a whole organ transplant. Their findings appear in Science Translational Medicine.
DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today it has completed enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of topical agents T4 endonuclease and photolyase to reduce DNA damage induced as measured through gene expression analysis.
› Verified 5 days ago
Theresa A Borrowman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 401 N 9th St, Bismarck, ND 58501 Phone: 701-712-4500 | |
David L Appert, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2830 N Washington St, Bismarck, ND 58503 Phone: 701-323-6400 Fax: 017-323-5677 | |
Dr. Joseph A Luger, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 701 E Rosser Ave, Bismarck, ND 58501 Phone: 701-751-9500 Fax: 701-751-9508 | |
Dr. Joseph Mark Ebertz, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2700 State St, Bismarck, ND 58503 Phone: 701-712-4500 Fax: 701-712-4011 | |
Dr. William Eugene Cornatzer Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 225 N 7th St # 2, United Bank Bldg, Bismarck, ND 58501 Phone: 701-224-1273 Fax: 701-323-2929 | |
Nicole Marie Soto, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2830 N Washington St, Bismarck, ND 58503 Phone: 701-323-6400 |